.svg){kind=small}
Aug-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Amend Cannabis has shown notable performance in the Missouri market across various categories. In the Tincture & Sublingual category, the brand maintained a consistent ranking at the fourth position from June through August 2024, following a slight improvement from fifth place in May. This steady rank indicates a strong market presence and customer loyalty in this category. However, it's worth noting that the sales figures in August saw a significant drop compared to July, which might suggest a seasonal fluctuation or increased competition.
In the Topical category within Missouri, Amend Cannabis started strong with a third-place ranking from May to July 2024. However, the brand experienced a drop to the fifth position in August. Despite this decline in ranking, the overall sales figures remained relatively stable until a notable decrease in August. This drop in both ranking and sales could indicate emerging competitors or shifting consumer preferences. It's crucial for stakeholders to monitor these trends closely to strategize effectively for future growth.
Competitive Landscape
In the Missouri Topical cannabis market, Amend Cannabis has experienced notable fluctuations in its competitive positioning over the past few months. Initially holding a strong third place from May to July 2024, Amend Cannabis saw a significant drop to fifth place in August 2024. This decline in rank is particularly concerning given the consistent performance of competitors such as Heartland Labs and Heartland Holistics, which maintained their fourth and fifth positions respectively, with Heartland Holistics even climbing to third place in August. Additionally, Vlasic Labs has shown steady growth, consistently holding the sixth position but with increasing sales each month. The absence of Drool in the top 20 for several months also highlights the volatility in this market. For Amend Cannabis, the drop in rank correlates with a noticeable decrease in sales in August, indicating potential challenges in maintaining market share amidst aggressive competition.
Notable Products
In August 2024, the top-performing product for Amend Cannabis was the CBD/THC 1:1 Amend Infused Balm (250mg CBD, 250mg THC) in the Topical category, maintaining its rank from June and achieving sales of 229 units. The CBD/THC 1:1 Amend Tincture (400mg CBD, 400mg THC) in the Tincture & Sublingual category secured the second position, consistent with its rank in June, though its sales dropped to 166 units. The CBD/THC 1:1 Amend Tincture (100mg CBD, 100mg THC, 30ml) ranked third, falling from its top position in May and July. The CBD/THC 1:1 Amend Infused Balm (50mg CBD, 50mg THC) rose to fourth place, showing improvement from its fifth rank in May and June. Lastly, the CBD/THC/CBC 1:1:1 Transdermal Lotion (50mg CBD, 50mg THC, 50mg CBC) ranked fifth, marking its debut in the top five since its introduction.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
